These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21820306)

  • 1. Pharmacodynamic synergy strictly dependent on the co-operative aggregation of enantiomers of cyclic peptides in the bacterial cell membrane.
    Danielsson M; Rosenthal-Aizman K; Bergsson G; Undén A
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5262-5. PubMed ID: 21820306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses of low-hemolytic antimicrobial gratisin peptides.
    Tamaki M; Kokuno M; Sasaki I; Suzuki Y; Iwama M; Saegusa K; Kikuchi Y; Shindo M; Kimura M; Uchida Y
    Bioorg Med Chem Lett; 2009 May; 19(10):2856-9. PubMed ID: 19369073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclo(D-Tyr-D-Phe): a new antibacterial, anticancer, and antioxidant cyclic dipeptide from Bacillus sp. N strain associated with a rhabditid entomopathogenic nematode.
    Nishanth Kumar S; Dileep C; Mohandas C; Nambisan B; Ca J
    J Pept Sci; 2014 Mar; 20(3):173-85. PubMed ID: 24353056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.
    Fernandez-Lopez S; Kim HS; Choi EC; Delgado M; Granja JR; Khasanov A; Kraehenbuehl K; Long G; Weinberger DA; Wilcoxen KM; Ghadiri MR
    Nature; 2001 Jul; 412(6845):452-5. PubMed ID: 11473322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobially active cycloundecapeptides related to gramicidin S having a novel turn structure with cis D-Phe-Pro peptide bond.
    Tamaki M; Sasaki I; Kokuno M; Shindo M; Kimura M; Uchida Y
    Org Biomol Chem; 2010 Apr; 8(8):1791-7. PubMed ID: 20449481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
    Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biological evaluation of some loloatin C analogues.
    Tuin AW; Grotenbreg GM; Spalburg E; de Neeling AJ; Mars-Groenendijk RH; van der Marel GA; Noort D; Overkleeft HS; Overhand M
    Bioorg Med Chem; 2009 Sep; 17(17):6233-40. PubMed ID: 19679485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
    Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antimicrobial properties of non-hemolytic cationic alpha-cyclopeptoids.
    Comegna D; Benincasa M; Gennaro R; Izzo I; De Riccardis F
    Bioorg Med Chem; 2010 Mar; 18(5):2010-8. PubMed ID: 20153656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic peptides from a Ruegeria strain of bacteria associated with the sponge Suberites domuncula.
    Mitova M; Popov S; De Rosa S
    J Nat Prod; 2004 Jul; 67(7):1178-81. PubMed ID: 15270577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.
    Monroc S; Badosa E; Feliu L; Planas M; Montesinos E; Bardají E
    Peptides; 2006 Nov; 27(11):2567-74. PubMed ID: 16730857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
    Conlon JM; Galadari S; Raza H; Condamine E
    Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
    Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
    J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin.
    Wu G; Wu H; Li L; Fan X; Ding J; Li X; Xi T; Shen Z
    Biochem Biophys Res Commun; 2010 Apr; 395(1):31-5. PubMed ID: 20331979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of human liver-expressed antimicrobial peptide 2.
    Hocquellet A; Odaert B; Cabanne C; Noubhani A; Dieryck W; Joucla G; Le Senechal C; Milenkov M; Chaignepain S; Schmitter JM; Claverol S; Santarelli X; Dufourc EJ; Bonneu M; Garbay B; Costaglioli P
    Peptides; 2010 Jan; 31(1):58-66. PubMed ID: 19852990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.
    Wang P; Nan YH; Yang ST; Kang SW; Kim Y; Park IS; Hahm KS; Shin SY
    Peptides; 2010 Jul; 31(7):1251-61. PubMed ID: 20363271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
    Glukhov E; Burrows LL; Deber CM
    Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.